Health Care Law, Workforce Management Lawyer, Litigation Attorney
Bradley Merrill Thompson Quoted in Article, "FDA Tells 23andMe to Pull Personal Genome Service"
Bloomberg BNA's Medical Devices Law & Industry Report
November 25, 2013 | Media Coverage | less than a minute
Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in an article titled “FDA Tells 23andMe to Pull Personal Genome Service.”